BRIEF published on 02/04/2026 at 19:58, 1 month 19 days ago ABIONYX Reports Monthly Voting Rights and Shares Update Euronext Paris Share Capital Voting Rights AMF Regulations ABIONYX Pharma
BRIEF published on 02/04/2026 at 19:58, 1 month 19 days ago ABIONYX publie un rapport mensuel sur les droits de vote et les actions. Euronext Paris Capital Social Droit De Vote ABIONYX Pharma Règlementation De L'AMF
BRIEF published on 02/04/2026 at 19:58, 1 month 19 days ago Droits de vote et actions d'ABIONYX sur Euronext Paris Euronext Paris Droits De Vote Capital Social AMF ABIONYX
BRIEF published on 02/04/2026 at 19:58, 1 month 19 days ago Voting rights and shares of ABIONYX on Euronext Paris Euronext Paris Share Capital Voting Rights AMF ABIONYX
PRESS RELEASE published on 02/04/2026 at 19:53, 1 month 19 days ago Inside Information / Other news releases ABIONYX Pharma releases monthly statement on total voting rights and shares. Company focuses on innovative medicines in rare diseases with lipid science expertise Shares Total Voting Rights Monthly Statement ABIONYX Pharma Innovative Medicines
PRESS RELEASE published on 02/04/2026 at 19:53, 1 month 19 days ago Informations privilégiées / Autres communiqués ABIONYX Pharma communique le nombre total de droits de vote et d'actions en circulation, soulignant son engagement envers les maladies inflammatoires sévères sans traitement efficace Droits De Vote Actions Maladies Inflammatoires Biopharma ABIONYX Pharma
BRIEF published on 01/28/2026 at 18:53, 1 month 26 days ago ABIONYX: Publication of the Number of Voting Rights and Shares Euronext Paris Share Capital Voting Rights Financial Transparency ABIONYX
BRIEF published on 01/28/2026 at 18:53, 1 month 26 days ago ABIONYX : Publication du Nombre de Droits de Vote et d'Actions Euronext Paris Droits De Vote Capital Social Transparence Financière ABIONYX
PRESS RELEASE published on 01/28/2026 at 18:48, 1 month 26 days ago Informations privilégiées / Autres communiqués ABIONYX Pharma communique le nombre de titres en circulation et de droits de vote, conformément aux réglementations en vigueur. Détails sur les actions et objectif de la société Droits De Vote Développement Biopharma ABIONYX Pharma Nombre De Titres
BRIEF published on 01/23/2026 at 19:05, 2 months ago ABIONYX Pharma annonce son calendrier financier pour 2026 Calendrier Financier Biopharma ABIONYX Pharma Mises À Jour 2026 Soins De La Septicémie
Published on 03/24/2026 at 07:00, 1 hour 32 minutes ago Panther Minerals Earns In Under Rubidium Ridge Project Option
Published on 03/24/2026 at 07:00, 1 hour 32 minutes ago Panther Completes Acquisition of Rubidium Ridge Project
Published on 03/23/2026 at 22:40, 9 hours 52 minutes ago Troubadour Announces Withdrawal of Non-Brokered Private Placements
Published on 03/24/2026 at 07:30, 1 hour 2 minutes ago Drägerwerk AG & Co. KGaA: Dräger with good order development, record net sales and significant increase in net profit in fiscal year 2025 – third dividend increase in a row
Published on 03/24/2026 at 07:23, 1 hour 8 minutes ago INDUS confirms a solid financial year 2025 – Proposed dividend of EUR 1.30 exceeds previous year
Published on 03/24/2026 at 07:00, 1 hour 31 minutes ago After strong fourth quarter, INFICON closes 2025 at record sales level
Published on 03/24/2026 at 07:00, 1 hour 31 minutes ago Curatis: Double-digit revenue growth in 2025 and major milestones for corticorelin achieved
Published on 03/24/2026 at 07:45, 47 minutes ago François Jackow’s appointment as a Board member will be submitted to the Annual General Meeting on May 7, 2026
Published on 03/24/2026 at 07:45, 47 minutes ago La nomination de François Jackow en tant que membre du Conseil d’administration sera soumise à l’Assemblée générale du 7 mai 2026
Published on 03/24/2026 at 07:30, 1 hour 2 minutes ago Gimv secures new EUR 400 million revolving credit facility to support accelerated growth ambitions
Published on 03/24/2026 at 07:30, 1 hour 2 minutes ago Gimv verzekert zich van een nieuwe Revolving Credit Facility van EUR 400 miljoen ter ondersteuning van de versnelde groeiambities
Published on 03/23/2026 at 19:08, 13 hours 24 minutes ago Reporting on share buyback transactions carried out between March 16 and March 20, 2026
